Miriam V Dwek Selected Research

Doxorubicin (Adriamycin)

1/2020	Cancer cells grown in 3D under fluid flow exhibit an aggressive phenotype and reduced responsiveness to the anti-cancer treatment doxorubicin.
1/2017	Cellular glycosylation affects Herceptin binding and sensitivity of breast cancer cells to doxorubicin and growth factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miriam V Dwek Research Topics

Disease

14	Neoplasms (Cancer) 01/2020 - 10/2002
11	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2006
6	Neoplasm Metastasis (Metastasis) 04/2019 - 10/2011
3	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 05/2012
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/2010
1	Prostatic Neoplasms (Prostate Cancer) 12/2010

Drug/Important Bio-Agent (IBA)

6	Helix lectinIBA 04/2019 - 06/2011
6	Proteins (Proteins, Gene)FDA Link 01/2017 - 05/2012
6	LectinsIBA 01/2015 - 06/2011
5	Polysaccharides (Glycans)IBA 04/2019 - 10/2011
5	Biomarkers (Surrogate Marker)IBA 04/2019 - 12/2010
4	AgglutininsIBA 04/2019 - 05/2012
3	Carrier Proteins (Binding Protein)IBA 04/2019 - 10/2011
3	Glycoproteins (Glycoprotein)IBA 01/2015 - 06/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2017
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 04/2019 - 10/2013
2	QuartzIBA 01/2017 - 05/2012
2	cadherin 5IBA 01/2016 - 01/2013
2	MucinsIBA 01/2015 - 06/2012
2	IntegrinsIBA 06/2012 - 10/2011
2	CarbohydratesIBA 05/2012 - 10/2011
2	ProteomeIBA 01/2006 - 10/2002
1	CollagenIBA 01/2020
1	osteoblast cadherinIBA 01/2020
1	Thomsen-Friedenreich antigenIBA 04/2019
1	AntigensIBA 04/2019
1	Immunoglobulin A (IgA)IBA 04/2019
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Trastuzumab (Herceptin)FDA Link 01/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017
1	AnnexinsIBA 01/2015
1	Codon (Codons)IBA 01/2015
1	Annexin A4IBA 01/2015
1	saccharide-binding proteinsIBA 01/2015
1	IsoflavonesIBA 07/2013
1	LignansIBA 07/2013
1	Phytoestrogens (Phytoestrogen)IBA 07/2013
1	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 01/2013
1	Coloring Agents (Dyes)IBA 01/2013
1	AntibodiesIBA 01/2013
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2013
1	AcetylgalactosamineIBA 06/2012
1	EpitopesIBA 06/2012
1	Polystyrenes (Polystyrene)IBA 05/2012
1	Galectins (Galectin)IBA 10/2011
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 10/2011
1	Cadherins (E-Cadherin)IBA 10/2011
1	Laminin (Merosin)IBA 10/2011
1	Indicators and Reagents (Reagents)IBA 06/2011
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2010

Therapy/Procedure

1	Radiotherapy 05/2022
1	Quantum Dots (Quantum Dot) 01/2013